![Andrew Harbottle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrew Harbottle
Direttore Tecnico/Scientifico/R&S presso MDNA Life Sciences, Inc.
Profilo
Andrew Harbottle is currently the Chief Science Officer at MDNA Life Sciences, Inc. He obtained a doctorate degree from Newcastle University.
Posizioni attive di Andrew Harbottle
Società | Posizione | Inizio |
---|---|---|
MDNA Life Sciences, Inc.
![]() MDNA Life Sciences, Inc. Medical/Nursing ServicesHealth Services MDNA Life Sciences, Inc. engages in the development of molecular tests based on the mitochondrial genome. It focuses on the development and commercial application of mitochondrial DNA based biomarkers for the early detection of prostate, ovarian and lung cancers, and endometriosis. The company was founded by Mark Birch-Machin, Robert Thayer, and Ryan L. Parr in 2001 and is headquartered in West Palm Beach, FL. | Direttore Tecnico/Scientifico/R&S | 01/11/2014 |
Formazione di Andrew Harbottle
Newcastle University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
MDNA Life Sciences, Inc.
![]() MDNA Life Sciences, Inc. Medical/Nursing ServicesHealth Services MDNA Life Sciences, Inc. engages in the development of molecular tests based on the mitochondrial genome. It focuses on the development and commercial application of mitochondrial DNA based biomarkers for the early detection of prostate, ovarian and lung cancers, and endometriosis. The company was founded by Mark Birch-Machin, Robert Thayer, and Ryan L. Parr in 2001 and is headquartered in West Palm Beach, FL. | Health Services |
- Borsa valori
- Insiders
- Andrew Harbottle